Table 1. Clinical and Laboratory Characteristics of the Study Patients at Entry.
Characteristic | Bile Acid Analysis (n= 56 ) | No Bile Acid Analysis (n= 94 ) | p value |
---|---|---|---|
Age, years | 41.8 (17.8-75.5) | 49.3 (20.3-73.6) | 0.0017 |
Duration of disease, years | 0.69 (0.04-7.5) | 1.62 (0.005-49.5) | 0.09 |
Female sex, n (%) | 23 (41) | 41 (44) | 0.76 |
Colitis, n (%) | 52 (93) | 63 (68) | 0.0004 |
Varices, n (%) | 8 (14) | 18 (19) | 0.36 |
Histologic stage, n (%) | |||
I | 15 (26) | 35 (38) | 0.09 |
II | 20 (35) | 20 (22) | 0.07 |
III | 13 (23) | 24 (26) | 0.54 |
IV | 10 (18) | 13 (14) | 0.47 |
Alkaline phosphatase* | 4.0 (1.2-12.5) | 3.3 (0.52-26.9) | 0.25 |
Aspartate aminotransferase* | 1.6 (0.6-4) | 1.9 (0.5-8.0) | 0.12 |
Bilirubin, mg/dL* | 0.9 (0.3-4.5) | 1 (0.3-7.2) | 0.18 |
Mayo risk score | 0.015 [(−1.05)-1.8] | 0.58 [(−1.4)-2.4] | 0.0015 |
Data are presented as the median (range) unless otherwise indicated.
Values represent multiples of the upper limits of normal.